EGFR-IN-92

EGFR-IN-92 (compound 15) is an allosteric inhibitor targeting both T790M and L858R double-mutated EGFR. It exhibits antiproliferative activity against H1975 non-small cell lung cancer (NSCLC) cells expressing these double mutations.